|
[1]SCHWEITZER A,HORN J,MIKOLAJCZYK RT,et al.Estimation of worldwide prevalence of chronic hepatitis B virus infection:a systematic review of data published between 1965 and 2013[J].Lancet,2015,386(10003):1546-1555.
|
|
[2]GENEVA.Guidlines for the prevention,care and treatment of persons with CHB infection[S/OL].2015,WHO,PMID:26225396.http://www.ncbi.nlm.nih.gov/pubmed/26226396.
|
|
[3]BUSCA A,KUMAR A.Innate immune responses in hepatitis B virus(HBV)infection[J].Virol J,2014,11:22.
|
|
[4]STEFAN F,FRANCIS V.Stealth and cunning:hepatitis B and hepatitis C viruses[J].Virol J,2005,79(15):9369-9380.
|
|
[5]ZHENG Q,ZHU YY,CHEN J,et al.Activated natural killer cells accelerate liver damage in patients with chronic hepatitis B virus infection[J].Clin Exp Immunol,2015,180(3):499-508.
|
|
[6]FISICARO P,VALDATTA C,BONI C,et al.Early kinetics of innate and adaptive immune responses during hepatitis B virus infection[J].Gut,2009,58(7):974-982.
|
|
[7]JU Y,HOU N,MENG J,et al.T cell immunoglobulin-and mucin-domain-containing molecule-3(Tim-3)mediates natural killer cell suppression in chronic hepatitis B[J].J Hepatol,2010,52(3):322-329.
|
|
[8]FERRARI C.HBV and the immune response[J].Liver Int,2015,35(Suppl 1):121-128.
|
|
[9]DUNN C,PEPPA D,KHANNA P,et al.Temporal analysis of early immune responses in patients with acute hepatitis B virus infection[J].Gastroenterology,2009,137(4):1289-1300.
|
|
[10]HEIBERG IL,PALLETT LJ,WINTHER TN,et al.Defective natural killer cell anti-viral capacity in paediatric HBV infection[J].Clin Exp Immunol,2015,179(3):466-476.
|
|
[11]EBERT G,PRESTON S,ALLISON C,et al.Cellular inhibitor of apoptosis proteins prevent clearance of hepatitis B virus[J].Proc Natl Acad Sci U S A,2015,112(18):5797-5802.
|
|
[12]XIA Y,STADLER D,LUCIFORA J,et al.Interferon-γand tumor necrosis factor-αproduced by T cells reduce the HBV persistence form,cccD NA,without cytolysis[J].Gastroenterology,2016,150(1):194-205.
|
|
[13]BENGSCH B,MARTIN B,THIMME R.Restoratin of HBV-specific CD8+T cell function by PD-1 blockade in inactive carrier patients is linked to T cell differentation[J].J Hepatol,2014,61(6):1212-1219.
|
|
[14]PROTZER U,MAINI MK,KNOLLE PA.Living in the liver:hepatic infections[J].Nat Rev Immunol,2012,12(3):201-213.
|
|
[15]BOLTJES A,MOVITA D,BOONSTRA A,et al.The role of kupffer cells in hepatitis B and hepatitis C virus infections[J].J Hepatol,2014,61(3):660-671.
|
|
[16]MOVITA D,KREEFFT K,BIESTA P,et al.Kupffer cells express a unique combination of phenotypic and functional characteristics compared with splenic and peritoneal macrophages[J].J Leukoc Biol,2012,92(4):723-733.
|
|
[17]YUE X,WANG H,ZHAO F,et al.Hepatitis B virus-induced calreticulin protein is involved in IFN resistance[J].J Immunol,2012,189(1):279-286.
|
|
[18]DUNN C,BRUNETTO M,REYNOLDS G,et al.Cytokines induced during chronic hepatitis B virus infection promote a pathway for NK cell-mediated liver damage[J].J Exp Med,2007,204(3):667-680.
|
|
[19]PURO R,SCHNEIDER RJ.Tumor necrosis factor activates a conserved innate antiviral response to hepatitis B virus that destabilizes nucleocapsids and reduces nuclear viral DNA[J].J Virol,2007,81(14):7351-7362.
|
|
[20]CHEN QY,LIU YH,LI JH,et al.DNA dependent activator of interferon-regulatory factors inhibits hepatitis B virus replication[J].World J Gastroenterol,2012,18(22):2850-2858.
|
|
[21]HAN Q,ZHANG C,ZHANG J,et al.Involvement of activation of PKR in HBx-siRNA-mediated innate immune effects on HBV inhibition[J].PLoS One,2011,6(12):e27931.
|
|
[22]GUO F,HAN Y,ZHAO X,et al.STING agonists induce antiviral immune response against hepatitias B virus[J].Antimicrob Agents Chemother,2015,59(2):1273-1281.
|
|
[23]YUEN MF,LAI CL.Hepatitis B in 2014:HBV research moves forward—receptors and reactivation[J].Nat Rev Gastroenterol Hepatol,2015,12(2):70-72.
|
|
[24]MOHAMADKHANI A,POURDADASH A,TAYEBI S,et al.The potential role of APOBEC3G in limiting replication of hepatitis B virus[J].Arab J Gastroenterol,2012,13(4):170-173.
|
|
[25]SONG ZW,MA YX,FU BQ,et al.Altered mRNA levels of MOV10,A3G,and IFN-αin patients with chronic hepatitis B[J].J Microbiol,2014,52(6):510-514.
|
|
[26]GUO H,JIANG D,MA D,et al.Activation of pattern recognition receptor-mediated innate immunity inhibits the replication of hepatitis B virus in human hepatocyte-derived cells[J].J Virol,2009,83(2):847-858.
|
|
[27]XIONG W,WANG X,LIU X,et al.Interferon-inducible MyD 88 protein inhibits hepatitis B virus replication[J].Virology,2004,319(2):306-314.
|
|
[28]HONG Y,ZHOU L,XIE H,et al.Innate immune evasion by hepatitis B virus-mediated downregulation of TRIF[J].Biochem Biophys Res Commun,2015,463(4):719-725.
|
|
[29]AYOOBI F,HASSANSHAHI G,ZAINODINI N,et al.Reduced expression of TRIF in chronic HBV infected Iranian patients[J].Clin Res Hepatol Gastroenterol,2013,37(5):491-495.
|
|
[30]KAISER WJ,OFFERMANN MK.Apoptosis induced by the tolllike receptor adaptor TRIF is dependent on its receptor interacting protein homotypic interaction motif[J].J Immunol,2005,174(8):4942-4952.
|
|
[31]ZHANG YY,HU KQ.Rethinking the pathogenesis of hepatitis B virus(HBV)infection[J].J Med Virol,2015,87(12):1989-1999.
|
|
[32]DONG ZJ,WEI HM,SUN R,et al.Involvement of natural killer cells in PolyⅠ:C-induced liver injury[J].J Hepatol,2004,41(6):966-973.
|
|
[33]BOLTJES A,van MONTFOORT N,BIESTA PJ,et al.Kupffer cells interact with hepatitis B surface antigen in vivo and in vitro,leading to proinflammatory cytokine production and natrue killer cell function[J].J Infect Dis,2015,211(8):1268-1278.
|
DownLoad: